NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Contributed by: GlobeNewswire

Tags

Healthcare

More Like This

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023